NCT06447727View on ClinicalTrials.gov

Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Colorectal Cancer Metastatic
Interventions
DRUG

SIRT with Yttrium-90 Microspheres

Selective Internal Radiation Therapy (SIRT) with Yttrium-90 \[90Y\] Microspheres Injection

DRUG

FOLFIRI and Bevacizumab

FOLFIRI and Bevacizumab

Trial Locations (1)

210009

RECRUITING

Zhongda Hospital，Southeast University, Nanjing

All Listed Sponsors
lead

Zhongda Hospital

OTHER